247 related articles for article (PubMed ID: 21266174)
1. Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice.
Tahara A; Matsuyama-Yokono A; Shibasaki M
Eur J Pharmacol; 2011 Mar; 655(1-3):108-16. PubMed ID: 21266174
[TBL] [Abstract][Full Text] [Related]
2. Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
Horm Metab Res; 2008 Dec; 40(12):880-6. PubMed ID: 18819058
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
Eur J Pharmacol; 2009 Mar; 605(1-3):170-6. PubMed ID: 19171131
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats.
Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Shibasaki M
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):560-8. PubMed ID: 18793271
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
6. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
[TBL] [Abstract][Full Text] [Related]
7. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
8. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
Tahara A; Takasu T; Yokono M; Imamura M; Kurosaki E
Arch Pharm Res; 2016 Feb; 39(2):259-270. PubMed ID: 26450351
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet.
Jang SM; Yee ST; Choi J; Choi MS; Do GM; Jeon SM; Yeo J; Kim MJ; Seo KI; Lee MK
Int Immunopharmacol; 2009 Jan; 9(1):113-9. PubMed ID: 19013541
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 diabetes mice induced by high-fat diet combining with streptozotocin via suppression of hepatic gluconeogenesis.
Li W; Zhang M; Gu J; Meng ZJ; Zhao LC; Zheng YN; Chen L; Yang GL
Fitoterapia; 2012 Jan; 83(1):192-8. PubMed ID: 22056666
[TBL] [Abstract][Full Text] [Related]
13. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
14. Acetaminophen normalizes glucose homeostasis in mouse models for diabetes.
Shertzer HG; Schneider SN; Kendig EL; Clegg DJ; D'Alessio DA; Genter MB
Biochem Pharmacol; 2008 Mar; 75(6):1402-10. PubMed ID: 18237716
[TBL] [Abstract][Full Text] [Related]
15. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice.
Xue J; Ding W; Liu Y
Fitoterapia; 2010 Apr; 81(3):173-7. PubMed ID: 19699280
[TBL] [Abstract][Full Text] [Related]
17. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
19. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
Nath S; Ghosh SK; Choudhury Y
J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
[TBL] [Abstract][Full Text] [Related]
20. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
